Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?

C. Dickhoff*, K. J. Hartemink, J. Kooij, P. M. van de Ven, M. A. Paul, E. F. Smit, M. Dahele

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)185
Number of pages1
JournalAnnals of Oncology
Volume28
Issue number1
DOIs
Publication statusPublished - 1 Jan 2017

Cite this